Atlas Trials

A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)

Clinical trial NCT02275351 · COMPLETED

Trial details

NCT number
NCT02275351
Sponsor
Biosplice Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Androgenetic Alopecia
Start date
2014-11-01
Primary completion
2015-11-01
Enrollment
310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.